side effects of glp 1 after stopping What Happens When Patients Stop Taking GLP-1 Drugs? New Cleveland Clinic Study Reveals Real World Insights What Really Happens When You

GLP-1 agonists In the late 1980s a group of scientists identified the first GLP-1 agonist (Exendin-4) in animals

One particularly serious concern is acromegalic cardiomyopathy, enlargement and weakening of the heart

A recent meta-analysis comprising nearly 300,000 individuals showed that patients with NAFLD have an increased risk of developing T2D compared to controls [hazard ratio (HR) 2.22, 95% CI 1.842.60], and that risk of T2D increases across the stages of NAFLD (9)

Similarly, patients prescribed SGLT2 inhibitors both before and after the procedure increased substantially from 0.9% in 2018 to 4.3% in 2023, once again calling into question the extent to which SGLT2 inhibitors are a replacement versus a supplemental therapy